Development of a peptide targeting dopamine transporter to improve ADHD-like deficits

Attention-deficit hyperactivity disorder (ADHD) is a neurocognitive disorder characterized by hyperactivity, inattention, working memory deficits and impulsivity. Its worldwide prevalence is estimated to be 3–5% in children and adolescents. The mainstay treatment for ADHD is stimulant medications (e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Terence K. Y., Su, Ping, Zhang, Hailong, Liu, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234781/
https://www.ncbi.nlm.nih.gov/pubmed/30413217
http://dx.doi.org/10.1186/s13041-018-0409-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234781/
https://www.ncbi.nlm.nih.gov/pubmed/30413217
http://dx.doi.org/10.1186/s13041-018-0409-0

Ejemplares similares